Topic
alternatives
10 articles
Best Yahoo Finance Alternative for Global Coverage
Yahoo Finance has basic filters and limited European data. Here are the best alternatives: deeper filters, reliable European coverage, better free tiers.
Best TradingView Alternative for Fundamental Investors
TradingView is the best charting platform available. If fundamental screening is your workflow, here are the best TradingView alternatives.
Best TIKR Alternative — Cheaper, Better European Coverage
TIKR is a solid data platform, but at $40–55/month it charges for depth most investors don't need. The best alternatives with better coverage, lower cost.
Best Stockopedia Alternative — Same Coverage, Half Price
Stockopedia charges €60–80/month and excludes US stocks from its cheaper plan. The best alternatives with full European coverage from €29/month.
Best Stock Rover Alternative for European Coverage
Stock Rover is a strong US and Canadian screener with deep history and portfolio analytics, but almost no European coverage. The best alternatives.
Best Simply Wall St Alternative for Fundamental Investors
Simply Wall St uses snowflake charts and simplified scores instead of raw data. If you want a real fundamental screener, here are the best alternatives.
Best Morningstar Alternative: Cheaper, Better Screening
Morningstar Premium costs $199–249/year and centers on analyst ratings and fund research, not screening. These alternatives offer deeper filters for less.
Best MarketScreener Alternative: Faster, Better UX
MarketScreener has strong analyst data but slow filters and a dated UX. Here are the best alternatives for European screening with instant filters.
Best Koyfin Alternative: Cheaper, Broader Coverage
Koyfin costs $39–79/month and centers on dashboards, not screening. Here are the best alternatives for fundamental screening and European small-cap data.
Why Serious Investors Outgrow Finviz
Finviz is where most investors start. It's rarely where they finish. Here's what drives experienced investors away — and what they use instead.